Group 1: Pharmaceutical Industry - The Trump administration is threatening to impose a 200% tariff on imported pharmaceuticals, with a timeline for companies to adjust of about one to one and a half years [2][3] - The Pharmaceutical Research and Manufacturers of America (PhRMA) opposes the tariffs, stating that every dollar spent on tariffs cannot be invested in U.S. manufacturing or future treatments [3] - Analysts believe that the announcement may have a positive impact on the pharmaceutical sector, as the tariffs are not expected to be implemented immediately and their future enforcement remains uncertain [2] Group 2: Copper Industry - Trump is considering a 50% additional tax on imported copper, although no specific implementation date has been provided [3][4] - Following the tariff announcement, copper prices surged over 10%, reaching a historical high in the New York market, with futures rising 13.12%, marking the largest single-day increase since 1989 [3][4] - The U.S. relies heavily on copper imports, with nearly half of its copper supply coming from abroad, primarily from Chile [4]
铜价飙升至新高！特朗普再挥大棒：威胁对铜和药品征收高额关税
Xin Lang Cai Jing·2025-07-09 00:23